The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells (original) (raw)
- Letter
- Published: 18 September 2017
- Brian F Pickering2 na1,
- Yuanming Cheng1 na1,
- Sara Zaccara2,
- Diu Nguyen1,
- Gerard Minuesa1,
- Timothy Chou1,
- Arthur Chow1,
- Yogesh Saletore3,
- Matthew MacKay3,
- Jessica Schulman4,
- Christopher Famulare5,
- Minal Patel5,
- Virginia M Klimek6,
- Francine E Garrett-Bakelman7,
- Ari Melnick8,
- Martin Carroll9,
- Christopher E Mason3,10,11,
- Samie R Jaffrey ORCID: orcid.org/0000-0003-3615-69582 &
- …
- Michael G Kharas ORCID: orcid.org/0000-0002-1165-69911
Nature Medicine volume 23, pages 1369–1376 (2017)Cite this article
- 28k Accesses
- 888 Citations
- 90 Altmetric
- Metrics details
Subjects
Abstract
_N_6-methyladenosine (m6A) is an abundant nucleotide modification in mRNA that is required for the differentiation of mouse embryonic stem cells. However, it remains unknown whether the m6A modification controls the differentiation of normal and/or malignant myeloid hematopoietic cells. Here we show that shRNA-mediated depletion of the m6A-forming enzyme METTL3 in human hematopoietic stem/progenitor cells (HSPCs) promotes cell differentiation, coupled with reduced cell proliferation. Conversely, overexpression of wild-type METTL3, but not of a catalytically inactive form of METTL3, inhibits cell differentiation and increases cell growth. METTL3 mRNA and protein are expressed more abundantly in acute myeloid leukemia (AML) cells than in healthy HSPCs or other types of tumor cells. Furthermore, METTL3 depletion in human myeloid leukemia cell lines induces cell differentiation and apoptosis and delays leukemia progression in recipient mice in vivo. Single-nucleotide-resolution mapping of m6A coupled with ribosome profiling reveals that m6A promotes the translation of c-MYC, BCL2 and PTEN mRNAs in the human acute myeloid leukemia MOLM-13 cell line. Moreover, loss of METTL3 leads to increased levels of phosphorylated AKT, which contributes to the differentiation-promoting effects of METTL3 depletion. Overall, these results provide a rationale for the therapeutic targeting of METTL3 in myeloid leukemia.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Accession codes
Accessions
Gene Expression Omnibus
References
- Meyer, K.D. et al. Comprehensive analysis of mRNA methylation reveals enrichment in 3′ UTRs and near stop codons. Cell 149, 1635–1646 (2012).
Article CAS Google Scholar - Dominissini, D. et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature 485, 201–206 (2012).
Article CAS Google Scholar - Geula, S. et al. Stem cells. m6A mRNA methylation facilitates resolution of naïve pluripotency toward differentiation. Science 347, 1002–1006 (2015).
Article CAS Google Scholar - Batista, P.J. et al. m6A RNA modification controls cell fate transition in mammalian embryonic stem cells. Cell Stem Cell 15, 707–719 (2014).
Article CAS Google Scholar - Li, Z. et al. FTO plays an oncogenic role in acute myeloid leukemia as a N6-methyladenosine RNA demethylase. Cancer Cell 31, 127–141 (2017).
Article Google Scholar - Mauer, J. et al. Reversible methylation of m6Am in the 5′ cap controls mRNA stability. Nature 541, 371–375 (2017).
Article CAS Google Scholar - Wang, X. et al. Corrigendum: Structural basis of N6-adenosine methylation by the METTL3-METTL14 complex. Nature 542, 260 (2017).
Article CAS Google Scholar - Lin, S., Choe, J., Du, P., Triboulet, R. & Gregory, R.I. The m6A methyltransferase METTL3 promotes translation in human cancer cells. Mol. Cell 62, 335–345 (2016).
Article CAS Google Scholar - Bagger, F.O. et al. BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis. Nucleic Acids Res. 44 D1, D917–D924 (2016).
Article CAS Google Scholar - Śledź, P. & Jinek, M. Structural insights into the molecular mechanism of the m(6)A writer complex. eLife 5, e18434 (2016).
Article Google Scholar - Wang, P., Doxtader, K.A. & Nam, Y. Structural basis for cooperative function of Mettl3 and Mettl14 methyltransferases. Mol. Cell 63, 306–317 (2016).
Article CAS Google Scholar - Wang, X. et al. Structural basis of N6-adenosine methylation by the METTL3-METTL14 complex. Nature 534, 575–578 (2016).
Article CAS Google Scholar - Shi, J. et al. Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains. Nat. Biotechnol. 33, 661–667 (2015).
Article CAS Google Scholar - Wang, T., et al. Gene essentiality profiling reveals gene networks and synthetic lethal interactions with oncogenic Ras. Cell 168, 890–903 (2017).
Article CAS Google Scholar - Linder, B. et al. Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome. Nat. Methods 12, 767–772 (2015).
Article CAS Google Scholar - Sommer, S., Lavi, U. & Darnell, J.E. Jr . The absolute frequency of labeled N-6-methyladenosine in HeLa cell messenger RNA decreases with label time. J. Mol. Biol. 124, 487–499 (1978).
Article CAS Google Scholar - Ingolia, N.T., Lareau, L.F. & Weissman, J.S. Ribosome profiling of mouse embryonic stem cells reveals the complexity and dynamics of mammalian proteomes. Cell 147, 789–802 (2011).
Article CAS Google Scholar - Wang, X. et al. N6-methyladenosine modulates messenger RNA translation efficiency. Cell 161, 1388–1399 (2015).
Article CAS Google Scholar - Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545–15550 (2005).
Article CAS Google Scholar - Park, S.M. et al. Musashi-2 controls cell fate, lineage bias, and TGF-β signaling in HSCs. J. Exp. Med. 211, 71–87 (2014).
Article CAS Google Scholar - Li, S. et al. Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia. Nat. Med. 22, 792–799 (2016).
Article CAS Google Scholar - Sarry, J.E. et al. Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rgc-deficient mice. J. Clin. Invest. 121, 384–395 (2011).
Article CAS Google Scholar - Stoneley, M. et al. c-Myc protein synthesis is initiated from the internal ribosome entry segment during apoptosis. Mol. Cell. Biol. 20, 1162–1169 (2000).
Article CAS Google Scholar - Pandey, S. & Wang, E. Cells en route to apoptosis are characterized by the upregulation of c-fos, c-myc, c-jun, cdc2, and RB phosphorylation, resembling events of early cell-cycle traverse. J. Cell. Biochem. 58, 135–150 (1995).
Article CAS Google Scholar - Sherrill, K.W., Byrd, M.P., Van Eden, M.E. & Lloyd, R.E. BCL-2 translation is mediated via internal ribosome entry during cell stress. J. Biol. Chem. 279, 29066–29074 (2004).
Article CAS Google Scholar - Ping, X.L. et al. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res. 24, 177–189 (2014).
Article CAS Google Scholar - Kharas, M.G. et al. Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice. Blood 115, 1406–1415 (2010).
Article CAS Google Scholar - Sykes, S.M. et al. AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias. Cell 146, 697–708 (2011).
Article CAS Google Scholar - Cui, Q. et al. m6A RNA methylation regulates the self-renewal and tumorigenesis of glioblastoma stem cells. Cell Reports 18, 2622–2634 (2017).
Article CAS Google Scholar - Zhang, S., et al. m6A demethylase ALKBH5 maintains tumorigenicity of glioblastoma stem-like cells by sustaining FOXM1 expression and cell proliferation program. Cancer Cell 31, 591–606 (2017).
Article CAS Google Scholar - Kwok, C.T., Marshall, A.D., Rasko, J.E. & Wong, J.J. Genetic alterations of m(6)A regulators predict poorer survival in acute myeloid leukemia. J. Hematol. Oncol. 10, 39 (2017).
Article Google Scholar - Patil, D.P. et al. m(6)A RNA methylation promotes XIST-mediated transcriptional repression. Nature 537, 369–373 (2016).
Article CAS Google Scholar - Olarerin-George, A.O. & Jaffrey, S.R. MetaPlotR: a Perl/R pipeline for plotting metagenes of nucleotide modifications and other transcriptomic sites. Bioinformatics 33, 1563–1564 (2017).
Article CAS Google Scholar - Bailey, T.L. et al. MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res. 37, W202–208 (2009).
Article Google Scholar - Kruse, S. et al. A novel synthesis and detection method for cap-associated adenosine modifications in mouse mRNA. Sci. Rep. 1, 126 (2011).
Article Google Scholar - Reid, D.W., Shenolikar, S. & Nicchitta, C.V. Simple and inexpensive ribosome profiling analysis of mRNA translation. Methods 91, 69–74 (2015).
Article CAS Google Scholar - Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
Article CAS Google Scholar - Love, M.I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
Article Google Scholar
Acknowledgements
We thank D. Bachovchin (MSKCC, New York) for the MOLM-13 constitutively expressing Cas9 cell line, and C. Vakoc (Cold Spring Harbor Laboratory, New York) for the constitutively expressing Cas9-RN2c cell line. We would like to thank the members of the Scaltriti laboratory (MSKCC, New York) for providing us with PI3K/AKT inhibitors. We thank the Weill Cornell Medicine Epigenomics Core for their assistance with sequencing. M.G.K. was supported by the US National Institutes of Health National Institute of Diabetes Digestive and Kidney Diseases Career Development Award, NIDDK NIH R01-DK101989-01A1, NCI 1R01CA193842-01, Kimmel Scholar Award, V-Scholar Award, Geoffrey Beene Award, Leukemia Lymphoma Society Career Development Award and Alex's Lemonade Stand A Award. This work was also supported by a Tri-Institutional Stem Cell Award (M.G.K. and S.R.J.), R01CA186702 (S.R.J.), T32CA062948 (B.F.P.), Ruth L. Kirschstein National Research Service Award 1F32CA22104-01 (B.F.P.), a Damon Runyon-Sohn Pediatric Cancer Fellowship Award DRSG10-14 (L.P.V.), and the American-Italian Cancer Foundation (S.Z.). The research was funded in part through the NIH/NCI Cancer Support Core Grant P30 CA08748 MGK. The RPPA core facility is funded by NCI #CA16672.
Author information
Author notes
- Ly P Vu, Brian F Pickering and Yuanming Cheng: These authors contributed equally to this work.
Authors and Affiliations
- Molecular Pharmacology Program, Center for Cell Engineering, Center for Stem Cell Biology, Center for Experimental Therapeutics, Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Ly P Vu, Yuanming Cheng, Diu Nguyen, Gerard Minuesa, Timothy Chou, Arthur Chow & Michael G Kharas - Department of Pharmacology, Weill Cornell Medicine, Cornell University, New York, New York, USA
Brian F Pickering, Sara Zaccara & Samie R Jaffrey - Department of Physiology and Biophysics, Weill Cornell Medicine, Cornell University, New York, New York, USA
Yogesh Saletore, Matthew MacKay & Christopher E Mason - Department of Medicine, Hematologic Oncology Tissue Bank, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Jessica Schulman - Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Christopher Famulare & Minal Patel - Department of Medicine, Memorial Sloan Kettering Cancer Center, Leukemia Service, New York, New York, USA
Virginia M Klimek - Department of Medicine and Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, Virginia, USA
Francine E Garrett-Bakelman - Division of Hematology and Medical Oncology, Department of Medicine and Department of Pharmacology, Weill Cornell Medicine, Cornell University, New York, New York, USA
Ari Melnick - Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Martin Carroll - The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medicine, New York, New York, USA
Christopher E Mason - The Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, New York, USA
Christopher E Mason
Authors
- Ly P Vu
You can also search for this author inPubMed Google Scholar - Brian F Pickering
You can also search for this author inPubMed Google Scholar - Yuanming Cheng
You can also search for this author inPubMed Google Scholar - Sara Zaccara
You can also search for this author inPubMed Google Scholar - Diu Nguyen
You can also search for this author inPubMed Google Scholar - Gerard Minuesa
You can also search for this author inPubMed Google Scholar - Timothy Chou
You can also search for this author inPubMed Google Scholar - Arthur Chow
You can also search for this author inPubMed Google Scholar - Yogesh Saletore
You can also search for this author inPubMed Google Scholar - Matthew MacKay
You can also search for this author inPubMed Google Scholar - Jessica Schulman
You can also search for this author inPubMed Google Scholar - Christopher Famulare
You can also search for this author inPubMed Google Scholar - Minal Patel
You can also search for this author inPubMed Google Scholar - Virginia M Klimek
You can also search for this author inPubMed Google Scholar - Francine E Garrett-Bakelman
You can also search for this author inPubMed Google Scholar - Ari Melnick
You can also search for this author inPubMed Google Scholar - Martin Carroll
You can also search for this author inPubMed Google Scholar - Christopher E Mason
You can also search for this author inPubMed Google Scholar - Samie R Jaffrey
You can also search for this author inPubMed Google Scholar - Michael G Kharas
You can also search for this author inPubMed Google Scholar
Contributions
L.P.V. led the project, performed experiments, analyzed data and wrote the manuscript. B.F.P., Y.C., D.N. and S.Z. performed experiments, analyzed data and edited the manuscript. G.M., T.C. and A.C. provided experimental supports. C.E.M., Y.S. and M.M. performed and analyzed MeRIP-seq experiments on patient-derived samples. J.S., C.F., M.P., F.E.G.-B., A.M., V.M.K. and M.C. provided patient samples. S.R.J. supervised the project and wrote the manuscript. M.G.K. directed the project, analyzed data and wrote the manuscript.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Corresponding authors
Correspondence toSamie R Jaffrey or Michael G Kharas.
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Rights and permissions
About this article
Cite this article
Vu, L., Pickering, B., Cheng, Y. et al. The _N_6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells.Nat Med 23, 1369–1376 (2017). https://doi.org/10.1038/nm.4416
- Received: 07 May 2017
- Accepted: 06 September 2017
- Published: 18 September 2017
- Issue Date: 01 November 2017
- DOI: https://doi.org/10.1038/nm.4416